Beta Drugs Acquires 66% Stake in IVF Specialist Nivian Lifesciences for ₹69.4 Crore
Published on: Jan. 12, 2026, 3:16 p.m. | Source: scanx.trade
Beta Drugs Ltd announced acquisition of 66.09% stake in IVF specialist Nivian Lifesciences for ₹69.4 crore, marking strategic entry into women's health segment. Stock surged 4% following announcement. Company reported H1 FY26 revenue growth of 13% to ₹203.6 crore, though net profit declined 2% to ₹23.9 crore.
